Medical Patent News

RSS

USPTO issues patent to Vandalia’s process for large-scale DNA production technology

Vandalia Research, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 8,163,489, covering Vandalia's process for large-scale DNA production using polymerase chain reaction.

18 May 2012

Codexis receives U.S. patent for enzymes utilized in HCV therapeutics

Codexis, Inc., a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that the United States Patent and Trademark Office (USPTO) has granted Codexis' patent covering the biocatalysts and biocatalytic processes used to make key pharmaceutical intermediates in the synthesis of leading hepatitis-C therapeutics.

16 May 2012

Lab21’s HCV drug resistance genotyping receives new patents in the U.S., Europe

Lab21 Limited, the Cambridge, UK-based specialist in personalised medicine has secured new patents in Europe and the USA relating to Hepatitis C (HCV) drug resistance as it continues to expand its intellectual property portfolio in infectious disease testing.

15 May 2012

OPKO receives U.S. patent allowance titled, ‘Flow Control in Microfluidic Systems’

OPKO Health, Inc. today announced the receipt of a patent allowance from the U.S. Patent and Trademark Office (USPTO) for the patent application titled "Flow Control in Microfluidic Systems".

15 May 2012

Helico reaches patent litigation settlement with Pacific Biosciences

Helicos BioSciences Corporation announced today that it has settled its patent infringement litigation against Pacific Biosciences, Inc.

15 May 2012

USPTO issues new patent to Excelsior Medical's SwabKIT

Excelsior Medical Corporation announced that the United States Patent and Trademark Office (USPTO) has issued new US Patent No. 8,167,847 to the company. The patent relates to an antiseptic cap and antiseptic cap equipped plunger and syringe barrel assembly.

15 May 2012

Trovagene receives European patent titled, ‘Methods for Detection of Nucleic Acid Sequences in Urine’

Trovagene, Inc., a developer of trans-renal molecular diagnostics, announced it has received notice of issuance of European Patent No. 2216416 entitled "Methods for Detection of Nucleic Acid Sequences in Urine."

11 May 2012

Shire, Cosmo and Giuliani International file suit against Watson over generic Lialda

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Mesalamine Delayed-release Tablets, 1.2g. Watson's ANDA product is a generic version of Shire Development LLC's Lialda.

10 May 2012

Integral Molecular receives U.S. patent for methodology that generates Lipoparticles

Integral Molecular, a leader in membrane protein reagents and services, announces the issuance of a key patent protecting its methodology for generating Lipoparticles, which provide highly-concentrated membrane proteins in their native conformation for antibody and drug discovery applications focused on membrane protein targets such as G protein-coupled receptors (GPCRs), ion channels, and transporters.

4 May 2012

Medical Brands' cranberry-based oral capsule granted Class IIa medical device status

Medical Brands has obtained a Class IIa medical device status through the appropriate Competent Authorities for Cranberry-Active, a patented cranberry-based oral capsule clinically shown to support urinary tract health.

2 May 2012

Inovio's SynCon vaccine for cervical dysplasias and cancers granted U.S. patent

Inovio Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 8,168,769, covering Inovio's SynCon vaccine for cervical dysplasias and cancers caused by human papillomavirus (HPV).

2 May 2012

Rexahn obtains additional patent coverage for anti-cancer candidate RX-1792 in Japan

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that the Japanese Patent Office has issued to the Company patent No. 4,934,432, entitled "Quinazoline Derivatives and Therapeutic Use Thereof."

30 Apr 2012

Teva, Mylan settle patent infringement litigation for Nuvigil

Teva Pharmaceutical Industries Ltd., one of the world's largest producers of pharmaceuticals, announces that it has settled patent infringement litigation regarding U.S. Patent Number 7,132,570 (the "'570 patent") with respect to Mylan Inc.'s ANDA for Teva's wakefulness product NUVIGIL (armodafinil) tablets.

30 Apr 2012

U.S. District Court rules in favor of Merck over ZETIA and VYTORIN patent litigation

Merck, known as MSD outside the United States and Canada, announced today that the U.S. District Court for the District of New Jersey has ruled in Merck's favor in two jointly related patent infringement suits against Mylan Pharmaceuticals Inc.

30 Apr 2012

IntegenX to accelerate commercialization of human DNA identification system with SV acquisition

IntegenX Inc., a privately held company that is a leader in the emerging field of rapid human DNA identification, today announced that it has acquired SV Corp, a wholly owned subsidiary of GE Healthcare Bio-Sciences. IntegenX will leverage SV Corp's products and intellectual property assets to expand its consumables offering and to accelerate the commercialization of its RapidHIT 200 Human DNA Identification System.

23 Apr 2012

Acetylon receives U.S. patent for ACY-1215 to treat multiple myeloma

Acetylon Pharmaceuticals Inc. today announced that it has been granted U.S. Patent 8,148,526 by the United States Patent and Trademark Office (USPTO). This patent contains fundamental composition of matter claims covering the Company's selective HDAC6 inhibitor, ACY-1215, which is currently being investigated in human clinical trials for the treatment of multiple myeloma.

21 Apr 2012

Depomed, Valeant file suit against Watson over generic Glumetza

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. – Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Metformin Hydrochloride Extended-release Tablets USP, 1000 mg.

20 Apr 2012

Supreme Court rules generic drug makers can challenge branded drug companies' wording in patent applications

The U.S. Supreme Court handed a victory to generic-drug companies Tuesday, ruling they can file certain legal counterclaims against brand-drug companies in an effort to get their cheaper copycat medicines on the market. The court, in an opinion written by Justice Elena Kagan, ruled unanimously that generic-drug makers should be allowed to challenge the way brand-name manufacturers describe their patents to the Food and Drug Administration.

19 Apr 2012

Impax initiates challenge of patents related to generic Gralise

Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed in the Orange Book in connection with Gralise (gabapentin tablets, 300 mg and 600 mg).

12 Apr 2012

USPTO issues two Notices of Allowance to AcelRx for NanoTab formulations

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that the U.S. Patent and Trademark Office (USPTO) has issued AcelRx two Notices of Allowance for the patent applications entitled "Small-Volume Oral Transmucosal Dosage Forms" and "Bioadhesive Drug Formulations for Oral Transmucosal Delivery."

12 Apr 2012

Medical Patent News

USPTO issues patent to Vandalia’s process for large-scale DNA production technology

Codexis receives U.S. patent for enzymes utilized in HCV therapeutics

Lab21’s HCV drug resistance genotyping receives new patents in the U.S., Europe

OPKO receives U.S. patent allowance titled, ‘Flow Control in Microfluidic Systems’

Helico reaches patent litigation settlement with Pacific Biosciences

USPTO issues new patent to Excelsior Medical's SwabKIT

Trovagene receives European patent titled, ‘Methods for Detection of Nucleic Acid Sequences in Urine’

Shire, Cosmo and Giuliani International file suit against Watson over generic Lialda

Integral Molecular receives U.S. patent for methodology that generates Lipoparticles

Medical Brands' cranberry-based oral capsule granted Class IIa medical device status

Inovio's SynCon vaccine for cervical dysplasias and cancers granted U.S. patent

Rexahn obtains additional patent coverage for anti-cancer candidate RX-1792 in Japan

Teva, Mylan settle patent infringement litigation for Nuvigil

U.S. District Court rules in favor of Merck over ZETIA and VYTORIN patent litigation

IntegenX to accelerate commercialization of human DNA identification system with SV acquisition

Acetylon receives U.S. patent for ACY-1215 to treat multiple myeloma

Depomed, Valeant file suit against Watson over generic Glumetza

Supreme Court rules generic drug makers can challenge branded drug companies' wording in patent applications

Impax initiates challenge of patents related to generic Gralise

USPTO issues two Notices of Allowance to AcelRx for NanoTab formulations

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News